en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


1/2012
vol. 50
 
Share:
Share:
abstract:
Case report

Osteolytic lesions in the pelvis of the patient with an aggressive form of psoriatic arthritis

Iwona Dankiewicz-Fares
,
Katarzyna Kolossa
,
Barbara Kościelniak
,
Sławomir Jeka

Reumatologia 2012; 50, 1: 57–60
Online publish date: 2012/03/02
View full text Get citation
 
Psoriatic arthritis (PsA) is a chronic, inflammatory disease. It occurs in 6 to 42% of patients suffering from psoriasis. The cause of both PsA and psoriasis is still unknown. In progressing PsA synovitis, bone erosion, osteolysis (distal phalanges, distal epiphysises of forearm and carpus bones) and new bone formation can be observed. PsA results in destructive abnormalities as well as simultaneous proliferation. The incidence of osteolytic abnormalities in iliac bone is not a typical sign of PsA. In the paper the case of a 48-year-old man, who was diagnosed with PsA 10 years earlier is presented. The patient was treated irregularly. There occured disease exacerbation, progressing devastation, decline in body mass, high inflammatory degree and osteolytic abnormalities in iliac bones that are usually associated with cancer. A wide imaging diagnosis had been carried out (KT of chest, KT of abdominal cavity, scintigraphy, PET), which did not confirm cancer development. Due to the lack of improvement during treatment with disease modifying drugs (methotrexate, cyclosporine), was decided to include biological agents for the treatment of anti TNF-α (infliximab, adalimumab).
keywords:

psoriatic arthritis, osteolytic lesions, cancer, biological treatment




Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.